Risk for Colorectal Neoplasia in Patients With Colonic Crohn's Disease and Concomitant Primary Sclerosing Cholangitis

Clinical Gastroenterology and Hepatology

Volumn 10, Issue 3, 2012, Pages 303-308

  Braden, Barbara ^a   Halliday, Johnny ^a   Aryasingha, Sanjeewa ^a   Sharifi, Yalda ^a   Checchin, Davide ^a   Warren, Bryan F ^a   Kitiyakara, Taya ^a   Travis, Simon P L ^a   Chapman, Roger W ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Colonoscopy; IBD; Inflammatory Bowel Syndrome; Screening

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RISK; COLITIS; COLON CARCINOGENESIS; COLON CROHN DISEASE; COLON POLYPOSIS; COLORECTAL CANCER; COLORECTAL DYSPLASIA; CONTROLLED STUDY; DYSPLASIA; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRIMARY SCLEROSING CHOLANGITIS; TERTIARY HEALTH CARE; ULCERATIVE COLITIS;

ADULT; AGED; CHOLANGITIS, SCLEROSING; COLORECTAL NEOPLASMS; CROHN DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 84857190704     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2011.10.020     Document Type: Article

References (35)

1. Loftus E.V. Epidemiology and risk factors for colorectal dysplasia and cancer in ulcerative colitis. Gastroenterol Clin North Am 2006, 35:517-531.
2. Shetty K., Rybicki L., Brzezinski A., et al. The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis. Am J Gastroenterol 1999, 94:1643-1649.
3. Jess T., Loftus E.V., Velayos F.S., et al. Risk factors for colorectal neoplasia in inflammatory bowel disease: a nested case-control study from Copenhagen county, Denmark and Olmsted county, Minnesota. Am J Gastroenterol 2007, 102:829-836.
4. Soetikno R.M., Lin O.S., Heidenreich P.A., et al. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis. Gastrointest Endosc 2002, 56:48-54.
5. Loftus E.V., Harewood G.C., Loftus C.G., et al. PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis. Gut 2005, 54:91-96.
6. Broomé U., Bergquist A. Primary sclerosing cholangitis, inflammatory bowel disease, and colon cancer. Semin Liver Dis 2006, 26:31-41.
7. Svrcek M., Cosnes J., Beaugerie L., et al. Colorectal neoplasia in Crohn's colitis: a retrospective comparative study with ulcerative colitis. Histopathology 2007, 50:574-583.
8. Cairns S.R., Scholefield J.H., Steele R.J., et al. Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut 2010, 59:666-689.
9. Mowat C., Cole A., Windsor A., et al. Guidelines for the management of inflammatory bowel disease in adults. Gut 2011, 60:571-607.
10. Riddell R.H., Goldman H., Ransohoff D.F., et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol 1983, 14:931-968.
11. Schlemper R.J., Riddell R.H., Kato Y., et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut 2000, 47:251-255.
12. Friedman S. Cancer in Crohn's disease. Gastroenterol Clin North Am 2006, 35:621-639.
13. Lindberg B.U., Broomé U., Persson B. Proximal colorectal dysplasia or cancer in ulcerative colitis. The impact of primary sclerosing cholangitis and sulfasalazine: results from a 20-year surveillance study. Dis Colon Rectum 2001, 44:77-85.
14. Heuschen U.A., Hinz U., Allemeyer E.H., et al. Backwash ileitis is strongly associated with colorectal carcinoma in ulcerative colitis. Gastroenterology 2001, 120:841-847.
15. Hill M.J., Melville D.M., Lennard-Jones J.E., et al. Faecal bile acids, dysplasia, and carcinoma in ulcerative colitis. Lancet 1987, 2:185-186.
16. Stadler J., Yeung K.S., Furrer R., et al. Proliferative activity of rectal mucosa and soluble fecal bile acids in patients with normal colons and in patients with colonic polyps or cancer. Cancer Lett 1988, 38:315-320.
17. Pardi D.S., Loftus E.V., Kremers W.K., et al. Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis. Gastroenterology 2003, 124:889-893.
18. Batta A.K., Salen G., Holubec H., et al. Enrichment of the more hydrophilic bile acid ursodeoxycholic acid in the fecal water-soluble fraction after feeding to rats with colon polyps. Cancer Res 1998, 58:1684-1687.
19. Thackeray E.W., Charatcharoenwitthaya P., Elfaki D., et al. Colon neoplasms develop early in the course of inflammatory bowel disease and primary sclerosing cholangitis. Clin Gastroenterol Hepatol 2011, 9:52-56.
20. Rutter M.D., Saunders B.P., Wilkinson K.H., et al. Cancer surveillance in longstanding ulcerative colitis: endoscopic appearances help predict cancer risk. Gut 2004, 53:1813-1816.
21. Askling J., Dickman P.W., Karlén P., et al. Family history as a risk factor for colorectal cancer in inflammatory bowel disease. Gastroenterology 2001, 120:1356-1362.
22. Velayos F.S., Terdiman J.P., Walsh J.M. Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: a systematic review and metaanalysis of observational studies. Am J Gastroenterol 2005, 100:1345-1353.
23. Friedman S., Rubin P.H., Bodian C., et al. Screening and surveillance colonoscopy in chronic Crohn's colitis: results of a surveillance program spanning 25 years. Clin Gastroenterol Hepatol 2008, 6:993-998. Quiz:53-54.
24. Rasmussen H.H., Fallingborg J.F., Mortensen P.B., et al. Hepatobiliary dysfunction and primary sclerosing cholangitis in patients with Crohn's disease. Scand J Gastroenterol 1997, 32:604-610.
25. Odze R.D., Farraye F.A., Hecht J.L., et al. Long-term follow-up after polypectomy treatment for adenoma-like dysplastic lesions in ulcerative colitis. Clin Gastroenterol Hepatol 2004, 2:534-541.
26. Ho G.T., Seddon A.J., Therapondos G., et al. The clinical course of ulcerative colitis after orthotopic liver transplantation for primary sclerosing cholangitis: further appraisal of immunosuppression post transplantation. Eur J Gastroenterol Hepatol 2005, 17:1379-1385.
27. Vera A., Gunson B.K., Ussatoff V., et al. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis. Transplantation 2003, 75:1983-1988.
28. Claessen M.M., Vleggaar F.P., Tytgat K.M., et al. High lifetime risk of cancer in primary sclerosing cholangitis. J Hepatol 2009, 50:158-164.
29. van Staa T.P., Card T., Logan R.F., et al. 5-aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological study. Gut 2005, 54:1573-1578.
30. Eaden J.A., Abrams K.R., Mayberry J.F. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001, 48:526-535.
31. Winther K.V., Jess T., Langholz E., et al. Long-term risk of cancer in ulcerative colitis: a population-based cohort study from Copenhagen County. Clin Gastroenterol Hepatol 2004, 2:1088-1095.
32. Rutter M.D., Saunders B.P., Wilkinson K.H., et al. Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis. Gastroenterology 2006, 130:1030-1038.
33. Lakatos L., Mester G., Erdelyi Z., et al. Risk factors for ulcerative colitis-associated colorectal cancer in a Hungarian cohort of patients with ulcerative colitis: results of a population-based study. Inflamm Bowel Dis 2006, 12:205-211.
34. Hurlstone D.P., Kiesslich R., Thomson M., et al. Confocal chromoscopic endomicroscopy is superior to chromoscopy alone for the detection and characterisation of intraepithelial neoplasia in chronic ulcerative colitis. Gut 2008, 57:196-204.
35. Kiesslich R., Fritsch J., Holtmann M., et al. Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology 2003, 124:880-888.